Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE)

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512407-39-00

Acronym

BRONCHIOLE-2017

Enrollment

1700

Registered

2024-07-09

Start date

Unknown

Completion date

2025-11-19

Last updated

2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Brief summary

A composite of time to death, exacerbations of COPD, and cardiovascular events (myocardial infarction, angina pectoris, heart failure, stroke, transient ischemic attack, or cerebral hemorrhage) recorded in the Swedish National Patient Register or in electronic primary care records (ICD codes I20, I21,122, I48, I50.1-9, I61, I63 or G45.9)

Detailed description

Time to death (all-cause and cause-specific), Time to exacerbation of COPD, Time to a cardiovascular event, Extensive health-economic analysis

Interventions

DRUGSeloken 100mg tablett

DRUGSeloken 50 mg tablett

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
A composite of time to death, exacerbations of COPD, and cardiovascular events (myocardial infarction, angina pectoris, heart failure, stroke, transient ischemic attack, or cerebral hemorrhage) recorded in the Swedish National Patient Register or in electronic primary care records (ICD codes I20, I21,122, I48, I50.1-9, I61, I63 or G45.9)	—

Secondary

Measure	Time frame
Time to death (all-cause and cause-specific), Time to exacerbation of COPD, Time to a cardiovascular event, Extensive health-economic analysis	—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026